Time Therapeutics Inc. — Form D/A

Time Therapeutics Inc. of New York, NY, a company, filed a Form D amendment with the SEC on 2023-07-28. The offering totals $25.0M, of which $7.8M was reported sold. Industry: Other.

Offering

Filed: 2023-07-28
Form: D/A
Accession: 0001745531-23-000001
Industry: Other
Exemptions: 06b
Total offering: $25.0M
Amount sold: $7.8M
Remaining: $17.2M
Investors: 5
Date of first sale: 2022-01-28
Revenue range: Decline to Disclose
SEC file number: 021-432786

Issuer

Name: Time Therapeutics Inc.
CIK: 0001745531
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 154 West 14th Street, Suite 6-110, New York, NY, 10010
Phone: 518-421-8814

Officers, directors & promoters (5)

Name	Role	Location
Theodore Maidenberg	Director	Redwood City, CA
Mohammad Saad Alam	Director	New York, NY
Mohammad Saad Alam	Executive Officer	New York, NY
Stuart Blitz	Director	New York, NY
Stuart Blitz	Executive Officer	New York, NY

Other filings by this issuer (7)

Filed	Form	Offering	Sold
2024-07-02	D	$15.0M	$12.8M
2022-02-08	D	$25.0M	$450K
2021-04-23	D	$595K	$595K
2020-09-30	D	$5.0M	$5.0M
2020-09-14	D	$100K	$59K
2020-09-14	D/A	$3.0M	$2.4M
2018-07-05	D	$3.0M	$150K

More